## **Core Concept**
Organophosphate compound (OPC) poisoning acts by inhibiting the enzyme **acetylcholinesterase**, leading to an accumulation of **acetylcholine** in the synaptic cleft and causing overstimulation of muscarinic and nicotinic receptors.

## **Why the Correct Answer is Right**
The correct answer, **Atropine**, is an **antimuscarinic agent** that effectively counteracts the muscarinic effects of OPC poisoning, such as bradycardia, salivation, lacrimation, and increased bronchial secretions. Atropine does not affect nicotinic receptors but is crucial in managing the muscarinic symptoms.

## **Why Each Wrong Option is Incorrect**
* **Option A:** While some sources may suggest pralidoxime (an antidote used in OPC poisoning) could be considered, it primarily reactivates acetylcholinesterase and does not directly counteract muscarinic effects like atropine does.
* **Option B:** This option is not specified but generally would not be correct if it does not directly relate to OPC poisoning treatment.
* **Option D:** Similarly, without specification, any drug not directly indicated for OPC poisoning treatment would be incorrect.

## **Clinical Pearl / High-Yield Fact**
In OPC poisoning, the treatment often involves both **atropine** and **pralidoxime**. Atropine is given to counteract muscarinic effects, and pralidoxime helps reactivate acetylcholinesterase. A key point is that **atropine** is specifically for muscarinic symptoms and does not address nicotinic effects or reactivate the enzyme.

## **Correct Answer:** . Atropine